COMERA LIFE SCIENCES
Comera Life Sciences is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient to produce.
COMERA LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2014-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.comeralifesciences.com
Total Employee:
1+
Status:
Closed
Contact:
617-871-2101
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Stock Details
Investors List
![]()
KBI Biopharma
KBI Biopharma investment in Series A - Comera Life Sciences
![]()
Phoenix Venture Partners
Phoenix Venture Partners investment in Series A - Comera Life Sciences
Key Employee Changes
Official Site Inspections
http://www.comeralifesciences.com Semrush global rank: 4.96 M Semrush visits lastest month: 1.72 K
- Host name: 104.21.87.18
- IP address: 104.21.87.18
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Comera Life Sciences"
Comera Life Sciences | Leading a Compassionate New Era of โฆ
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation. May 9, 2022. Comera announced it has entered into a โฆSee details»
Our Story โ Comera Life Sciences | Leading a Compassionate โฆ
Comera is built on the belief that true medical advances are inspired by compassion. By scientific innovators seeing themselves in patients and their families. Feeling their burden. And being โฆSee details»
Comera Life Sciences - LinkedIn
Comera Life Sciences is a formulation innovator for protein therapeutics. Our proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using our ...See details»
Comera Life Sciences - Crunchbase Company Profile & Funding
Organization. Comera Life Sciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Comera Life Sciences is an โฆSee details»
Comera Life Sciences 2025 Company Profile: Stock
Nov 26, 2019 Comera Life Sciences General Information Description. Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated โฆSee details»
Comera Life Sciences Holdings, Inc. - AnnualReports.com
Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms.See details»
Comera Life Sciences, Inc. - Dun & Bradstreet
Comera Life Sciences, Inc. D&B Business Directory HOME / BUSINESS DIRECTORY / MANUFACTURING / CHEMICAL MANUFACTURING / PHARMACEUTICAL AND MEDICINE โฆSee details»
Comera Life Sciences Holdings Company Description - Stock โฆ
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation โฆSee details»
Comera Life Sciences Org Chart + Executive Team - The Official โฆ
Organizational Chart of Comera Life Sciences. Comera Life Sciences Org Chart www.ir.comeralifesciences.com +1 617 871 2101; Add an executive. Comera Life Sciences โฆSee details»
Comera Life Sciences Company Profile - Office Locations ... - Craft
Comera Life Sciences (formerly known as ReForm Biologics) is a pharmaceutical technology company focused on protein therapeutics. Its proprietary technology provides excipients for a โฆSee details»
Organization: Comera Life Sciences Holdings - Cbonds.com
Organization: Comera Life Sciences Holdings Organization name. Comera Life Sciences Holdings Inc ... Comera Life Sciences is applying a deep knowledge of formulation science and โฆSee details»
Our People โ Comera Life Sciences | Leading a Compassionate โฆ
Meet the people who create science from compassion to change the realities of patients with significant disease.See details»
Comera Life Sciences Holdings, Inc. (CMRA): history, ownership, โฆ
Comera Life Sciences' Financial Performance Given that Comera Life Sciences is in the clinical stage, traditional financial performance metrics such as revenue and profit are not applicable. โฆSee details»
Comera Life Sciences Holdings, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Comera Life Sciences Holdings, Inc. of Woburn, MA. Get the latest business insights from Dun & Bradstreet.See details»
Comera Life Sciences - Overview, News & Similar companies
Jan 4, 2024 Comera Life Sciences to Participate in Four Upcoming Conferences WOBURN, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: โฆSee details»
Comera Life Sciences - VentureRadar
Comera Life Sciences' proprietary formulation platform, SQoreโข, is designed to transform intravenous (โIVโ) biologics into subcutaneous (โSQโ) versions that patients can self-administer โฆSee details»
ReForm Biologics Changes Name to Comera Life Sciences
Jan 27, 2022 About Comera Life Sciences. Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to โฆSee details»
Comera Life Sciences Debuts as Publicly Traded Company Focused โฆ
May 20, 2022 Comera Life Sciences Holdings, Inc., the resulting combined company, will commence trading on the Nasdaq Capital Market under the symbol โCMRAโ on May 20, 2022. โฆSee details»
Comera Life Sciences IPO: What You Need to Know
May 20, 2022 Comera Life Sciences Holdings, Inc is a biotech company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and โฆSee details»
Comera Life Sciences Announces Bridge Financing and Exercise of โฆ
WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (โComeraโ or the โCompanyโ), a life sciences company developing a โฆSee details»